Hypoglycaemia during Treatment of Type 2 Diabetes: Dangerous Complication….. But Avoidable with Modern Non-Insulin Therapy

  • Ashok R Chandra Rao 228, AKG Nagar, Peroorkada, Trivandrum 695005
  • Dinesh D Prabhu SUT Academy of Medical Sciences, Vencode, Trivandrum & Consultant Diabetologist
Keywords: Hypoglycaemia, Type 2 diabetes, Pioglitazone, GLP-1 mimetics, DPP4 inhibitors, SGLT2 inhibitors

Abstract

Hypoglycaemia is a dangerous complication that could occur while treating diabetes. Inpatients with type 2 diabetes, avoidance of hypoglycaemia is desirable in all; and absolutely necessary in many. Currently, clinicians have access to a variety of medications that achieve the dual objective of reaching targets and avoiding hypoglycaemia.
This brief review aims to highlight the dangers of hypoglycaemia and to familiarize clinicians with non-insulin based medications that avoid hypoglycaemia while treating patients with type 2 diabetes mellitus.

Author Biography

Dinesh D Prabhu, SUT Academy of Medical Sciences, Vencode, Trivandrum & Consultant Diabetologist

Assistant Professor, Department of Medicine

Published
2016-09-29
Section
Review Article